Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
63
ANGO Quote, Financials, Valuation and Earnings
Last price:
$13.63
Seasonality move
:
5.1%
Day range:
$13.39 - $13.99
52-week range:
$6.92 - $13.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.86x
P/B ratio:
3.14x
Volume:
490K
Avg. volume:
482.3K
1-year change:
90.76%
Market cap:
$561.1M
Revenue:
$292.5M
EPS (TTM):
-$0.78
Analysts' Opinion
-
Consensus RatingAngioDynamics, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $19.33, AngioDynamics, Inc. has an estimated upside of 41.95% from its current price of $13.62.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $16.00 representing -17.47% downside risk from its current price of $13.62.
Fair Value
-
According to the consensus of 3 analysts, AngioDynamics, Inc. has 41.95% upside to fair value with a price target of $19.33 per share.
ANGO vs. S&P 500
-
Over the past 5 trading days, AngioDynamics, Inc. has overperformed the S&P 500 by 10.6% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
AngioDynamics, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AngioDynamics, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter AngioDynamics, Inc. reported revenues of $75.7M.
Earnings Growth
-
AngioDynamics, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter AngioDynamics, Inc. reported earnings per share of -$0.26.
Enterprise value:
532M
EV / Invested capital:
--
Price / LTM sales:
1.86x
EV / EBIT:
--
EV / Revenue:
1.77x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-29.90x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
297.86x
Gross Profit (TTM):
$152.4M
Return On Assets:
-11.33%
Net Income Margin (TTM):
-10.67%
Return On Equity:
-17.24%
Return On Invested Capital:
-16.73%
Operating Margin:
-10.43%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-08-31 | 2024-08-31 | 2025-08-31 | 2024-08-31 | 2025-08-31 | |
| Income Statement | ||||||
| Revenue | $335.9M | $292.7M | $300.7M | $67.5M | $75.7M | |
| Gross Profit | $154.4M | $139.4M | $152.4M | $34.2M | $39.2M | |
| Operating Income | -$20.9M | -$32.8M | -$23.2M | -$8.7M | -$7.9M | |
| EBITDA | $10.9M | -$5M | $1.8M | -$1.9M | -$1.9M | |
| Diluted EPS | $0.15 | -$6.04 | -$0.78 | -$0.31 | -$0.26 | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $131.3M | $151.4M | $175.5M | $172.6M | $156.7M | |
| Total Assets | $555.8M | $557.7M | $493.9M | $293.6M | $265.6M | |
| Current Liabilities | $52.1M | $66.4M | $57.5M | $76.7M | $68.3M | |
| Total Liabilities | $119.8M | $143.6M | $66.1M | $97M | $86.8M | |
| Total Equity | $436M | $414M | $427.8M | $196.6M | $178.9M | |
| Total Debt | $34.1M | $53.8M | $2.9M | $3.5M | $7.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-08-31 | 2024-08-31 | 2025-08-31 | 2024-08-31 | 2025-08-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$370K | -$20.5M | -$8.5M | -$18.3M | -$15.9M | |
| Cash From Investing | $92.3M | $22.9M | -$9.3M | -$2.4M | -$1.6M | |
| Cash From Financing | -$59.3M | -$5.2M | $1.1M | -$509K | $143K | |
| Free Cash Flow | -$9.6M | -$32.9M | -$17.8M | -$20.7M | -$17.5M | |
ANGO
Sector
Market Cap
$561.1M
$28.4M
Price % of 52-Week High
97.36%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-0.18%
-1.32%
1-Year Price Total Return
90.76%
-22.19%
Beta (5-Year)
0.489
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$12.86
200-day SMA
Buy
Level
$10.24
Bollinger Bands (100)
Buy
Level
9.37 - 12.15
Chaikin Money Flow
Sell
Level
-4.8M
20-day SMA
Buy
Level
$12.38
Relative Strength Index (RSI14)
Buy
Level
71.88
ADX Line
Buy
Level
23.85
Williams %R
Sell
Level
-14.0083
50-day SMA
Buy
Level
$11.90
MACD (12, 26)
Buy
Level
0.39
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Sell
Level
-611.5K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5922)
Buy
CA Score
(Annual)
Level (0.2448)
Buy
Beneish M-Score
(Annual)
Level (-2.8973)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (2.5466)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
Stock Forecast FAQ
In the current month, ANGO has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ANGO average analyst price target in the past 3 months is $19.33.
-
Where Will AngioDynamics, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that AngioDynamics, Inc. share price will rise to $19.33 per share over the next 12 months.
-
What Do Analysts Say About AngioDynamics, Inc.?
Analysts are divided on their view about AngioDynamics, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AngioDynamics, Inc. is a Sell and believe this share price will drop from its current level to $16.00.
-
What Is AngioDynamics, Inc.'s Price Target?
The price target for AngioDynamics, Inc. over the next 1-year time period is forecast to be $19.33 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ANGO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AngioDynamics, Inc. is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ANGO?
You can purchase shares of AngioDynamics, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AngioDynamics, Inc. shares.
-
What Is The AngioDynamics, Inc. Share Price Today?
AngioDynamics, Inc. was last trading at $13.63 per share. This represents the most recent stock quote for AngioDynamics, Inc.. Yesterday, AngioDynamics, Inc. closed at $13.62 per share.
-
How To Buy AngioDynamics, Inc. Stock Online?
In order to purchase AngioDynamics, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ANGO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ANGO
Sector
P/E ratio
--
23.66x
PEG ratio
0.00x
-0.01x
P/B ratio
3.14x
1.84x
Price / LTM sales
1.86x
1.60x
Growth Metrics
ANGO
Sector
Revenue growth
12.18%
4.85%
Earnings growth
15.88%
11.15%
Revenue (5-year growth)
2.06%
6.45%
Earnings forecast
-$0.10
-$0.20
Profitability
ANGO
Sector
Profitability FY 2025
$147.4M
$3.6M
Return on invested capital
-16.73%
-30.98%
Return on assets
-11.33%
-27.62%
Return on equity
-17.24%
-36.69%
Earnings Date
Last Earnings Date
Oct
2
Next Earnings Date
Jan
8
Estimated Next Earnings Date
Jan
1
Balance Sheet
ANGO
Sector
Total cash
$38.8M
$27.2M
Short term investments
--
$25.7M
Total assets
$280.1M
$79.9M
Long term debt
$7.8M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
44
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
